Rapid Experimentation: The Silicon Valley Method of Success

The methodology of rapid experimentation focuses on discovering a problem’s solutions through leap-offaith assumptions that will delight the end users. Rapid experimentation has been used by Silicon Valley in developing products and services that have excited consumers and changed business expectations. Developers need to have high functioning team members that are open to new experiences and that can deliver experiences to customers from products and services that not only exceed customer expectations, but delight them. In this paper, we present a case using this Silicon Valley methodology of rapid experimentation in solving the problem of substance abuse. We reflect on two team’s efforts in finding a solution to the problem of substance abuse. Starting at the same time, using the same resources, and having access to the same information, each team found a different solution. Both solutions are valid as both exceeded and delighted the users. Furthermore, this case illustrates that the application of rapid experimentation can be injected into classrooms to develop critical thinking and problem-solving skills

The Economic Value of Water: Results of a Workshop in Caracas, Venezuela, November 2000

In November 2000 a small workshop of 14 people met in Caracas, Venezuela, to discuss the value\u27 of water. The meeting was sponsored by the International Water Resources Network (IWRN), the Organization of American States (OAS), The Nature Conservancy, the University of New Mexico, and the National Oceanic and Atmospheric Administration (NOAA). The meeting was hosted by Jose Ochoa-Iturbe, Director of the School of Civil Engineering at the Universidad Catolica Andres Bello. The participants represented a mix of academics, water administrators, government officials and NGOs (non-governmental organizations) from around the Americas. Although many of the participants are economists, multiple disciplines and perspectives were represented. The meeting occurred as part of a process for stimulating discussion about water issues in the Americas. During and after IWRN\u27s Dialog III in Panama, the participants at a session on water valuation discussed the need for an intermediate meeting that would keep the discussion moving forward. The feeling was that the time interval between Dialogs was too long and significant time was spent at each Dialog repeating conversations that had occurred before. An intermediate conference was organized in Caracas to fill that need. This document was produced as a result of the Caracas meeting and is meant to serve as an input to IWRN\u27s Dialog IV in Brazil. The document should not be looked on as the final word but as an intermediate step meant to stimulate additional discussion

Evaluating water controls on vegetation growth in the semi-arid sahel using field and earth observation data

Water loss is a crucial factor for vegetation in the semi-arid Sahel region of Africa. Global satellite-driven estimates of plant CO2 uptake (gross primary productivity, GPP) have been found to not accurately account for Sahelian conditions, particularly the impact of canopy water stress. Here, we identify the main biophysical limitations that induce canopy water stress in Sahelian vegetation and evaluate the relationships between field data and Earth observation-derived spectral products for up-scaling GPP. We find that plant-available water and vapor pressure deficit together control the GPP of Sahelian vegetation through their impact on the greening and browning phases. Our results show that a multiple linear regression (MLR) GPP model that combines the enhanced vegetation index, land surface temperature, and the short-wave infrared reflectance (Band 7, 2105-2155 nm) of the moderate-resolution imaging spectroradiometer satellite sensor was able to explain between 88% and 96% of the variability of eddy covariance flux tower GPP at three Sahelian sites (overall = 89%). The MLR GPP model presented here is potentially scalable at a relatively high spatial and temporal resolution. Given the scarcity of field data on CO2 fluxes in the Sahel, this scalability is important due to the low number of flux towers in the region

Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC). Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS).

AbstractIn view of the increasing complexity of both cardiovascular implantable electronic devices (CIEDs) and patients in the current era, practice guidelines, by necessity, have become increasingly specific. This document is an expert consensus statement that has been developed to update and further delineate indications and management of CIEDs in pediatric patients, defined as ≤21 years of age, and is intended to focus primarily on the indications for CIEDs in the setting of specific disease categories. The document also highlights variations between previously published adult and pediatric CIED recommendations and provides rationale for underlying important differences. The document addresses some of the deterrents to CIED access in low- and middle-income countries and strategies to circumvent them. The document sections were divided up and drafted by the writing committee members according to their expertise. The recommendations represent the consensus opinion of the entire writing committee, graded by class of recommendation and level of evidence. Several questions addressed in this document either do not lend themselves to clinical trials or are rare disease entities, and in these instances recommendations are based on consensus expert opinion. Furthermore, specific recommendations, even when supported by substantial data, do not replace the need for clinical judgment and patient-specific decision-making. The recommendations were opened for public comment to Pediatric and Congenital Electrophysiology Society (PACES) members and underwent external review by the scientific and clinical document committee of the Heart Rhythm Society (HRS), the science advisory and coordinating committee of the American Heart Association (AHA), the American College of Cardiology (ACC), and the Association for European Paediatric and Congenital Cardiology (AEPC). The document received endorsement by all the collaborators and the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS). This document is expected to provide support for clinicians and patients to allow for appropriate CIED use, appropriate CIED management, and appropriate CIED follow-up in pediatric patients

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry

Individuals with primary immunodeficiency disorder may excrete poliovirus for extended periods and will constitute the only remaining reservoir of virus after eradication and withdrawal of oral poliovirus vaccine. Here, we analyzed the epidemiology of prolonged and chronic immunodeficiency-related vaccine-derived poliovirus cases in a registry maintained by the World Health Organization, to identify risk factors and determine the length of excretion. Between 1962 and 2016, there were 101 cases, with 94/101 (93%) prolonged excretors and 7/101 (7%) chronic excretors. We documented an increase in incidence in recent decades, with a shift toward middle-income countries, and a predominance of poliovirus type 2 in 73/101 (72%) cases. The median length of excretion was 1.3 years (95% confidence interval: 1.0, 1.4) and 90% of individuals stopped excreting after 3.7 years. Common variable immunodeficiency syndrome and residence in high-income countries were risk factors for long-term excretion. The changing epidemiology of cases, manifested by the greater incidence in recent decades and a shift to from high- to middle-income countries, highlights the expanding risk of poliovirus transmission after oral poliovirus vaccine cessation. To better quantify and reduce this risk, more sensitive surveillance and effective antiviral therapies are needed

Estimating the Extent of Vaccine-Derived Poliovirus Infection

BACKGROUND: Eight outbreaks of paralytic polio attributable to circulating vaccine-derived poliovirus (cVDPV) have highlighted the risks associated with oral poliovirus vaccine (OPV) use in areas of low vaccination coverage and poor hygiene. As the Polio Eradication Initiative enters its final stages, it is important to consider the extent to which these viruses spread under different conditions, so that appropriate strategies can be devised to prevent or respond to future cVDPV outbreaks. METHODS AND FINDINGS: This paper examines epidemiological (temporal, geographic, age, vaccine history, social group, ascertainment), and virological (type, genetic diversity, virulence) parameters in order to infer the numbers of individuals likely to have been infected in each of these cVDPV outbreaks, and in association with single acute flaccid paralysis (AFP) cases attributable to VDPVs. Although only 114 virologically-confirmed paralytic cases were identified in the eight cVDPV outbreaks, it is likely that a minimum of hundreds of thousands, and more likely several million individuals were infected during these events, and that many thousands more have been infected by VDPV lineages within outbreaks which have escaped detection. CONCLUSIONS: Our estimates of the extent of cVDPV circulation suggest widespread transmission in some countries, as might be expected from endemic wild poliovirus transmission in these same settings. These methods for inferring extent of infection will be useful in the context of identifying future surveillance needs, planning for OPV cessation and preparing outbreak response plans